Recombinant Xenopus laevis Leucine-rich repeat flightless-interacting protein 2 (LRRFIP2), partial, refers to a genetically engineered version of the LRRFIP2 protein derived from the African clawed frog, Xenopus laevis. This protein is involved in various cellular processes, including Toll-like receptor signaling and Wnt signaling pathways. The term "partial" indicates that the recombinant protein may not include the full sequence of the native protein.
LRRFIP2 is known to interact with the Disheveled (Dvl) protein in the Wnt signaling pathway, enhancing beta-catenin levels and activating transcriptional activities dependent on beta-catenin/LEF/TCF . It also plays a role in Toll-like receptor signaling by disrupting the interaction between MyD88 and Flightless I, a negative regulator of NF-κB activity .
Double Axis Formation: Expression of LRRFIP2 in Xenopus embryos leads to double axis formation, indicating its role in embryonic development through the Wnt pathway .
Wnt Target Gene Expression: LRRFIP2 enhances the expression of Wnt target genes, further supporting its function in this pathway .
Positive Regulation: LRRFIP2 acts as a positive regulator in Toll-like receptor signaling by facilitating the interaction between MyD88 and downstream effectors .
Interaction with Flightless I: It disrupts the inhibitory interaction between MyD88 and Flightless I, enhancing NF-κB activity .
Recombinant proteins like LRRFIP2 are typically produced in host organisms such as Escherichia coli or mammalian cells. The production process involves cloning the gene encoding LRRFIP2 into an expression vector, which is then introduced into the host cells. The recombinant protein can be purified using various tags, such as His-tags, for further analysis or application in research studies.
| Characteristic | Description |
|---|---|
| Species | Xenopus laevis |
| Protein Name | LRRFIP2, partial |
| Function | Wnt and TLR signaling |
| Expression System | Typically E. coli or mammalian cells |
| Purification Tag | His-tag or similar |
| Application | Description |
|---|---|
| Cell Signaling | Study of Wnt and TLR pathways |
| Embryonic Development | Analysis of axis formation in Xenopus embryos |
| Immunology | Investigation of immune response modulation |
May function as an activator of the canonical Wnt signaling pathway upstream of β-catenin (ctnnb1). May be required for dorsal axis formation.
KEGG: xla:444248
UniGene: Xl.77399
LRRFIP2 (Leucine-rich repeat flightless-interacting protein 2) is a protein that functions as an activator of the canonical Wnt signaling pathway. The protein contains several distinct structural domains that are critical for its function. At the amino terminus, there is a serine-rich region that serves as a potential site for post-translational modifications . The carboxyl terminus contains a predicted coiled-coil domain that is highly conserved across species . Between these regions is a central portion that mediates interaction with Flightless-I .
LRRFIP2 was first identified as a potent activator of Wnt signaling through a comprehensive genome-wide functional screen. In this screen, LRRFIP2 emerged as one of the strongest positive regulators, inducing the TOPflash reporter activity (a standard assay for Wnt pathway activation) 20-30 fold over background levels . The human LRRFIP2 gene was initially discovered in a two-hybrid screen using human Flightless-I as bait, though its functional significance remained unknown at that time .
Following its identification in humans, researchers isolated a cDNA encoding the long form of Xenopus LRRFIP2 from an embryonic cDNA library using PCR . The high degree of conservation between human and Xenopus LRRFIP2 facilitated this cross-species identification. Initial characterization involved testing its ability to activate Wnt signaling in both cell culture systems and in Xenopus embryos. In HEK293T cells, LRRFIP2 robustly activated the TOPflash reporter in a dose-dependent manner and increased cytoplasmic β-catenin levels . In Xenopus embryos, microinjection of LRRFIP2 RNA into the ventral marginal zone at the two-cell stage induced secondary axis formation with high penetrance (80%), a phenotype consistent with ectopic activation of Wnt signaling .
The shorter form of LRRFIP2 is expressed at high levels maternally and throughout early development, suggesting it plays important roles during early embryogenesis . The longer form, in contrast, is only detected at low levels after the midblastula transition (the point at which zygotic gene transcription begins), becoming readily detectable after stage 14 (neurulation) . This temporal regulation of alternative splicing suggests that the functional capacity of LRRFIP2 might be developmentally regulated, potentially contributing to stage-specific aspects of Wnt signaling.
The presence of LRRFIP2 during early development, particularly the maternal expression of the shorter form, positions it to potentially participate in early developmental processes including axis specification. This expression pattern aligns with the phenotypic effects observed when LRRFIP2 function is perturbed through overexpression or dominant negative approaches .
LRRFIP2 functions as a positive regulator of the canonical Wnt signaling pathway through a mechanism that involves interaction with Disheveled (Dvl) and subsequent stabilization of β-catenin. The process follows a specific sequence of molecular events that ultimately leads to the transcription of Wnt target genes .
The mechanism begins with LRRFIP2 binding to the central region of Dvl, which contains the PDZ and DEP domains. This interaction likely facilitates the activation of Dvl, which then inhibits GSK-3β (glycogen synthase kinase 3β) . In the absence of LRRFIP2-mediated activation, GSK-3β phosphorylates β-catenin, marking it for ubiquitination and subsequent degradation by the proteasome. When LRRFIP2 activates Dvl and inhibits GSK-3β, β-catenin escapes phosphorylation and degradation, leading to its accumulation in the cytoplasm . This has been experimentally verified by Western blot analysis showing increased levels of cytoplasmic β-catenin in HEK293T cells expressing LRRFIP2 .
The accumulated β-catenin subsequently translocates to the nucleus where it interacts with TCF/LEF (T cell factor/lymphocyte enhancer factor) transcription factors, converting them from transcriptional repressors to activators of Wnt target genes . This activation of the Wnt pathway by LRRFIP2 has been confirmed using reporter assays with the TOPflash reporter, which contains multiple TCF/LEF binding sites upstream of a luciferase gene .
The functionality of LRRFIP2 depends critically on its interactions with other proteins, primarily Disheveled (Dvl), a key adaptor protein in the Wnt signaling pathway. This interaction has been characterized through deletion analysis and functional studies .
The interaction between LRRFIP2 and Dvl is mediated specifically by the amino terminus of LRRFIP2, which binds to the central region of Dvl containing the PDZ and DEP domains . This interaction is essential for LRRFIP2 function, as deletion mutants lacking the amino terminus lose the ability to activate Wnt signaling . Similarly, the carboxyl terminus, which contains the predicted coiled-coil domain, is also required for LRRFIP2 function, though its specific interaction partners are not as clearly defined in the available data .
LRRFIP2 may function as a scaffold protein that facilitates the activation of Dvl, leading to the stabilization of β-catenin . This scaffolding role is supported by the observation that disruption of the LRRFIP2-Dvl interaction with a dominant negative form of LRRFIP2 (containing only the amino terminus) abolishes the activities of both proteins .
Experimental manipulation of LRRFIP2 expression in Xenopus embryos produces distinct phenotypes that provide insight into its developmental functions. These phenotypes vary depending on whether LRRFIP2 is overexpressed or its function is inhibited using dominant negative constructs .
When LRRFIP2 is overexpressed through injection of synthetic RNA into the ventral marginal zone of two-cell-stage embryos, it induces axis duplication with high penetrance (80% of injected embryos) . Histological analysis reveals that the LRRFIP2-induced second axis contains a secondary notochord and neural tube that are morphologically indistinguishable from those in the primary axis . This phenotype is consistent with ectopic activation of the canonical Wnt signaling pathway, which is known to induce secondary axis formation when activated in the ventral side of early Xenopus embryos .
At the molecular level, overexpression of LRRFIP2 in animal cap explants strongly induces the expression of Wnt target genes Siamois and Xnr3 to levels comparable to those induced by β-catenin . These genes are part of the Spemann organizer gene network that is essential for proper dorsal axis specification .
Conversely, inhibition of LRRFIP2 function using a dominant negative form (containing only the amino terminus) produces opposite effects. This dominant negative LRRFIP2 significantly reduces double axis formation induced by xWnt8 . When injected at multiple positions along the dorsal-ventral axis, it results in hypodorsalized phenotypes in a small but reproducible number of embryos, characterized by reduced head structures that are indicative of reduced Wnt signaling . Additionally, some embryos exhibit defects in gastrulation that might reflect the role of Wnt signaling in convergent extension movements .
Several methodological approaches have proven effective for the expression and purification of recombinant Xenopus LRRFIP2, each with specific advantages depending on the experimental context and research objectives .
For in vitro expression, the full-length cDNA encoding Xenopus LRRFIP2 can be isolated from an embryonic cDNA library by PCR and inserted into an appropriate expression vector containing a strong promoter . When selecting expression systems, HEK293T cells have been successfully used to produce functional LRRFIP2 protein that effectively activates the TOPflash reporter in a dose-dependent manner . This mammalian expression system provides the necessary cellular machinery for proper folding and potential post-translational modifications of LRRFIP2.
For biochemical studies requiring larger amounts of protein, bacterial expression systems using E. coli can be employed, though care must be taken to ensure proper folding of the recombinant protein. Including solubility-enhancing tags such as MBP (maltose-binding protein) or SUMO may improve the yield of correctly folded protein. For purification purposes, affinity tags such as His6, FLAG, or GST can be added, preferably at positions that don't interfere with the amino or carboxyl terminal domains that are critical for LRRFIP2 function .
For embryological studies, capped synthetic LRRFIP2 RNAs can be generated using in vitro transcription systems and subsequently used for microinjection into specific regions of Xenopus embryos . When working with LRRFIP2, it's important to consider which form to express. The long form shows maximal activity in Wnt signaling assays, while the short form (lacking amino acids 61-294) has lower efficiency . This difference should be taken into account when designing experiments to study LRRFIP2 function.
Dominant negative LRRFIP2 constructs can be designed based on the structural and functional domains of the protein, with validation occurring through multiple complementary approaches .
The most effective dominant negative form of LRRFIP2 identified in research (referred to as LRRFIP2-M5) contains only the amino terminus of the protein . This region interacts with Disheveled but lacks the domains necessary for activating downstream signaling, effectively competing with endogenous LRRFIP2 for binding to Dvl . This design strategy is based on the finding that both the amino and carboxyl termini of LRRFIP2 are required for its function in activating Wnt signaling .
Validation of dominant negative constructs begins with reporter assays in cell culture. An effective dominant negative construct should suppress TOPflash reporter activation induced by wild-type LRRFIP2 or other Wnt pathway activators such as xWnt8 . This can be tested in HEK293T cells, which provide a clean system for assessing the effects of the construct on Wnt pathway activation.
The second validation step involves demonstrating that the dominant negative construct maintains the ability to bind to Disheveled but fails to activate downstream signaling components. This can be confirmed through co-immunoprecipitation assays showing that the dominant negative LRRFIP2 still interacts with Dvl .
The most stringent validation comes from in vivo assays in Xenopus embryos. A true dominant negative LRRFIP2 should:
Suppress double axis formation induced by xWnt8 (the dominant negative LRRFIP2-M5 significantly reduces the percentage of embryos showing axis duplication when co-injected with xWnt8)
Have little or no effect on double axis formation induced by β-catenin, confirming that it acts upstream of β-catenin in the Wnt pathway
Produce phenotypes consistent with reduced Wnt signaling when injected alone, such as hypodorsalized embryos with reduced head structures
Multiple complementary assays have been developed and validated for studying LRRFIP2 function in Wnt signaling, ranging from molecular and biochemical approaches to developmental and phenotypic analyses .
At the molecular level, luciferase reporter assays provide a quantitative measure of LRRFIP2's ability to activate the Wnt pathway. The TOPflash reporter, which contains multiple TCF/LEF binding sites upstream of a luciferase gene, is particularly useful, as LRRFIP2 has been shown to activate this reporter 20-30 fold over background . The FOPflash reporter, containing mutated TCF/LEF binding sites, serves as a negative control to confirm specificity . Additionally, other reporter constructs (e.g., p53-responsive reporter, sonic hedgehog-responsive reporter) can be used to verify that LRRFIP2 specifically activates the Wnt pathway and not other signaling pathways .
Biochemical assays include Western blot analysis to assess changes in cytoplasmic β-catenin levels in response to LRRFIP2 expression . This directly demonstrates LRRFIP2's effect on β-catenin stability, a key step in canonical Wnt signaling. Co-immunoprecipitation assays are valuable for studying the interaction between LRRFIP2 and Disheveled or other potential binding partners .
For developmental analyses, several Xenopus embryo-based assays have proven informative. The secondary axis formation assay involves injecting LRRFIP2 RNA into the ventral marginal zone of two-cell-stage embryos and assessing axis duplication . The animal cap assay allows examination of gene expression changes in isolated animal cap tissue after LRRFIP2 injection . RT-PCR can then be used to measure the expression of Wnt target genes like Siamois and Xnr3 .
For loss-of-function studies, injection of dominant negative LRRFIP2 constructs provides a means to assess the requirement for LRRFIP2 in normal development . Co-injection of this construct with xWnt8 can be used to test its ability to inhibit xWnt8-induced secondary axis formation .
LRRFIP2 exhibits a distinctive pattern of evolutionary conservation that provides insights into its functional significance across different taxonomic groups .
The evolutionary picture changes dramatically when examining invertebrates. Complete LRRFIP2 homologs are notably absent in model invertebrates such as Caenorhabditis elegans or Drosophila . Instead, only partial homology exists with specific regions of LRRFIP2. The gene CG8578-PA (accession no. AAF48525) in Drosophila and F57B9.7 (accession no. AAM48538) in C. elegans are partially homologous to only the carboxyl terminus of LRRFIP2 .
In crustaceans, the evolutionary story is more complex. The shrimp Litopenaeus vannamei contains seven LRRFIP2 protein variants (LvLRRFIP2A-G), all containing a DUF2051 domain . This suggests that in some invertebrate lineages, LRRFIP2-like proteins may have undergone independent evolution and diversification.
The lack of complete homologs in most invertebrates suggests that LRRFIP2 may not represent a core component of ancestral Wnt signaling but rather emerged as a vertebrate-specific modulator that expands the signaling potential of the pathway . This places LRRFIP2 in the same category as other vertebrate-specific Wnt modulators such as Dkk1, Frodo, and Dapper, which add new levels of regulation during embryonic development .
The evolutionary divergence of LRRFIP2 across vertebrates and invertebrates is reflected in significant functional differences between these homologs .
In vertebrates, LRRFIP2 functions primarily as a modulator of canonical Wnt signaling. Through its interaction with Disheveled, LRRFIP2 promotes β-catenin stabilization and the activation of TCF/LEF-dependent transcription . This role in Wnt signaling directly impacts embryonic development, particularly axis specification in Xenopus, where LRRFIP2 overexpression induces secondary axis formation . The protein structure in vertebrates includes a serine-rich region at the amino terminus, a central region, and a coiled-coil domain at the carboxyl terminus, all contributing to its function in developmental signaling .
In invertebrates where LRRFIP2-like proteins exist, they appear to have evolved divergent functions. In the shrimp Litopenaeus vannamei, LRRFIP2 variants are upregulated in hemocytes (immune cells) after challenge with various pathogens including lipopolysaccharide, poly I:C, CpG-ODN2006, Vibrio parahaemolyticus, Staphylococcus aureus, and white spot syndrome virus . This suggests a primary role in immune response rather than developmental patterning. Dual-luciferase reporter assays in Drosophila Schneider 2 cells have shown that L. vannamei LRRFIP2 activates the promoters of antimicrobial peptide genes, further supporting its immune-related function .
Structurally, all seven L. vannamei LRRFIP2 variants contain a DUF2051 domain, but may lack other functional domains present in vertebrate LRRFIP2 . The knockdown of L. vannamei LRRFIP2 by RNA interference results in higher cumulative mortality upon V. parahaemolyticus infection, demonstrating its protective role in bacterial defense .
These differences suggest divergent evolutionary paths for LRRFIP2-like proteins, with vertebrates utilizing them primarily for developmental regulation through Wnt signaling, while some invertebrates have adapted similar proteins for immune functions.
Several lines of evidence collectively suggest that LRRFIP2 functions as a vertebrate-specific modulator of the Wnt signaling pathway rather than a core component of ancestral Wnt signaling .
First, the phylogenetic distribution of LRRFIP2 is notably restricted to vertebrates, with no complete homologs found in model invertebrates such as Caenorhabditis elegans or Drosophila . While some invertebrates like the shrimp Litopenaeus vannamei contain LRRFIP2-like proteins, these appear to serve primarily immune functions rather than developmental roles . This phylogenetic pattern suggests that LRRFIP2 emerged relatively recently in evolutionary history, coinciding with the increased complexity of vertebrate developmental programs.
Second, LRRFIP2 functions as a modulator rather than a core component of the Wnt pathway. Core components of signaling pathways typically show strong conservation across all metazoans, while modulators that fine-tune pathway activity often show more restricted taxonomic distribution. LRRFIP2 falls into this latter category, functioning to enhance Wnt signaling through interaction with Disheveled but not being absolutely required for all aspects of Wnt signaling . The dominant negative form of LRRFIP2 produces hypodorsalized phenotypes in only a small but reproducible number of embryos, suggesting a modulatory rather than essential role .
Third, LRRFIP2 shares characteristics with other known vertebrate-specific Wnt modulators such as Dkk1, Frodo, and Dapper . Like these proteins, LRRFIP2 appears to have evolved to expand the signaling potential of the Wnt pathway, adding a new level of regulation during embryonic development . This expansion of regulatory complexity coincides with the increased developmental complexity of vertebrates compared to invertebrates.
Finally, the functional data from Xenopus shows that LRRFIP2 regulates developmental processes that are characteristic of vertebrates, such as the formation of the dorsal organizer and the establishment of the primary body axis . These developmental events involve vertebrate-specific refinements of the Wnt signaling pathway.
Researchers investigating LRRFIP2 in developmental contexts face several significant methodological challenges that require careful experimental design and interpretation .
One major challenge stems from the existence of multiple LRRFIP2 isoforms with different activities. In Xenopus, both long and short forms of LRRFIP2 exist, with the short form showing weaker activity in Wnt signaling assays . These isoforms are dynamically expressed during development, with the shorter form expressed maternally and throughout early development, while the longer form appears after the midblastula transition . This complexity necessitates isoform-specific approaches and careful consideration of which form to target in functional studies. Using reagents that affect all isoforms may obscure isoform-specific functions, while targeting specific isoforms requires highly selective tools.
Temporal regulation presents another significant challenge. The expression and alternative splicing of LRRFIP2 changes during development, suggesting stage-specific functions . Perturbation of LRRFIP2 function at different developmental stages may produce different phenotypes, requiring precise temporal control of experimental manipulations. Technologies such as photo-activatable morpholinos or inducible dominant negative constructs may be necessary to achieve this temporal precision.
Functional redundancy with other Wnt pathway components may mask the effects of LRRFIP2 manipulation. The observation that dominant negative LRRFIP2 produces phenotypes in only a subset of injected embryos suggests potential compensatory mechanisms . This redundancy necessitates combinatorial approaches targeting multiple pathway components simultaneously to reveal the full function of LRRFIP2.
The context-dependency of LRRFIP2 function presents additional challenges. LRRFIP2 may function differently in different tissues or developmental contexts, as suggested by observations of both dorsalization phenotypes and gastrulation defects in Xenopus embryos injected with dominant negative LRRFIP2 . This requires tissue-specific perturbation approaches and detailed phenotypic analysis across multiple developmental processes.
Finally, distinguishing direct from indirect effects of LRRFIP2 manipulation is challenging in the complex environment of a developing embryo. LRRFIP2's role in Wnt signaling means that its perturbation can affect multiple downstream processes, making it difficult to identify its primary developmental functions.
The research literature on LRRFIP2 contains some apparently contradictory findings that require careful analysis and reconciliation to develop a coherent understanding of its function .
One apparent contradiction relates to the phenotypic effects of dominant negative LRRFIP2 in Xenopus embryos. When injected at multiple positions along the dorsal-ventral axis, dominant negative LRRFIP2 produces hypodorsalized phenotypes in only a small but reproducible number of embryos . This relatively mild effect seems at odds with the potent activity of wild-type LRRFIP2 in inducing secondary axis formation (80% penetrance) and strongly activating the TOPflash reporter (20-30 fold over background) .
This apparent contradiction can be reconciled by considering several factors. First, functional redundancy within the Wnt pathway may compensate for the inhibition of LRRFIP2. Second, maternal expression of LRRFIP2 may provide sufficient protein to resist the effects of the dominant negative construct, especially if the protein has a long half-life. Third, the dominant negative construct may not completely inhibit all forms of LRRFIP2, particularly if there are splice variants with different sensitivities to inhibition .
Another apparent contradiction emerges when comparing the developmental roles of LRRFIP2 in vertebrates with the immune functions of LRRFIP2-like proteins in invertebrates such as shrimp . This functional divergence can be reconciled by recognizing that proteins often evolve new functions through duplication and subfunctionalization. The structural similarity between vertebrate and invertebrate LRRFIP2 proteins may reflect a common ancestral protein that was recruited for different functions in different lineages.
The seemingly contradictory finding that LRRFIP2 induces axis duplication through Wnt activation but also produces gastrulation defects suggests involvement in multiple aspects of Wnt signaling . This can be reconciled by recognizing that Wnt signaling has distinct roles in different developmental processes: the canonical pathway regulates dorsal axis specification, while non-canonical Wnt pathways regulate cell movements during gastrulation. LRRFIP2 may interface with both aspects of Wnt signaling through its interaction with Disheveled, which participates in both canonical and non-canonical pathways .
Several promising research directions could significantly advance our understanding of LRRFIP2 biology and its roles in development and disease .
A comprehensive analysis of LRRFIP2 interaction partners beyond Disheveled and Flightless-I would provide deeper insight into its molecular functions. Advanced proteomics approaches such as BioID or proximity labeling could identify novel binding partners in different developmental contexts. This could reveal whether LRRFIP2 participates in protein complexes beyond those currently known and whether these interactions change during development or in different tissues.
The regulation of LRRFIP2 itself remains poorly understood and represents a promising research direction. The protein contains a serine-rich region that is a potential site for post-translational modifications . Investigating how LRRFIP2 is regulated by phosphorylation or other modifications could reveal mechanisms that modulate its activity in different developmental contexts. Additionally, the factors controlling the alternative splicing of LRRFIP2 during development could provide insight into how its function is developmentally regulated.
The potential role of LRRFIP2 in non-canonical Wnt pathways merits investigation. The observation of gastrulation defects in Xenopus embryos expressing dominant negative LRRFIP2 hints at involvement in convergent extension movements, which are regulated by non-canonical Wnt signaling . Detailed analysis of cell behaviors in embryos with perturbed LRRFIP2 function could reveal roles beyond canonical Wnt pathway activation.
The functional significance of LRRFIP2 in mammalian development remains relatively unexplored compared to its role in Xenopus. Given the high conservation between frog and human LRRFIP2, studying its function in mammalian model systems using CRISPR-Cas9 gene editing could reveal conserved and divergent aspects of its biology. The potential medical relevance of LRRFIP2 in human developmental disorders or cancers with aberrant Wnt signaling also warrants investigation.
Finally, comparative studies of LRRFIP2 function across different species could provide insight into how this protein evolved from a putative immune regulator in invertebrates to a developmental signaling modulator in vertebrates . Understanding this functional evolution could reveal fundamental principles about how signaling pathways are modified during evolution to accommodate increased developmental complexity.